Samantha J. Drennan
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG "PARCT".
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 09, 2024
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition.
Journal: Nature immunology
Published: March 29, 2022
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 25, 2018
IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.
Journal: Leukemia
Published: July 07, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026